Obstructive Lung Disease Flashcards
Short acting B2 Agonist
Albuterol
Tx for acute asthma exacerbation
Albuterol
Long acting agents (2) for prophylaxis
Salmeterol/Formoterol
AE: Tremor/Arrhythmia
Salmeterol/Formoterol
Inhaled Corticosteroids (2)
Fluticasone/Budesonide
Others: ‘sone’ & ‘ide’
Beclomethasone, Mometasone, Ciclesonide
MOA of inhaled corticosteroids (i.e.: Fluticasone/Budesonide)
Inhibits cytokine synthesis; Inactivates NF-KB, transcription factor that induces production of TNF alpha and other inflammatory agents
1st line therapy for chronic asthma (2)
Fluticasone/Budesonide
AE: oral thrush (2)
Fluticasone/Budesonide
Muscarinic Antagonists (2)
Tiotropium/Ipratroprium
MOA of muscarinic antagonists (i.e.: Tiotropium/Ipratroprium)
Competitively block muscarinic receptors, preventing bronchoconstriction T
Long acting muscarinic antagonists (2)
Tiotropium; Aclidinium
Antileukotrienes (2)
Montelukast/Zafirlukast
MOA of antileukotrienes (i.e.: Montelukast/Zafirlukast)
block leukotriene receptors (CysLT1)
5-lipoxygenase pathway inhibitor; blocks conversion of arachidonic acid to leukotrienes
Zileuton, antileukotriene
Anti-IgE monoclonal antibody
Omalizumab
MOA of Omalizumab
binds unbound serum IgE & blocks FCERI binding
Tx for allergic asthma w/ increased IgE levels
Omalizumab
Methylxanthines (2)
Theophylline, Roflumilast
MOA of Theophylline
Blocks action of adenosine
Metabolized by cytochrome P-450
↑cAMP due to ↓cAMP hydrolysis
Methylxanthine w/ limited use bc of narrow TI
Theophylline
non-specific muscarinic receptor M3 agonist to diagnose asthma
Methalcholine
MOA of Cromolyn
“mast cell stabilizer”
Inhibits mediator release from mast cells
↓ chemotaxis
sensory nerve effects (↓ cough, neuropeptide release)